Non anticoagulant effects of heparin: Implications for animal models of peritoneal dialysis

Peritoneal Dialysis International

Volumn 21, Issue SUPPL. 3, 2001, Pages

  De Vriese, An S ^a   Mortier, Siska ^a   Lameire, Norbert H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Animal models; Extracellular matrix; Glycosaminoglycans; Heparin

Indexed keywords

CHONDROITIN SULFATE; GLUCOSE; GLYCOSAMINOGLYCAN; HEPARIN; HYALURONIC ACID; N ACETYLGLUCOSAMINE; PERITONEAL DIALYSIS FLUID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GLUCOSE ABSORPTION; HOMEOSTASIS; HUMAN; INFLAMMATORY CELL; MOUSE; NONHUMAN; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEUM ADHESION; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TRANSPORT; ULTRAFILTRATION;

EID: 0035571717     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102103s65     Document Type: Article

References (29)

1. More to "heparin" than anticoagulation
2. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: The role of mesothelial cells
3. Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis
4. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat
5. Heparin in inflammation: Potential therapeutic applications beyond anticoagulation
6. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
7. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides
8. Regulation of cellular proliferation by heparin and heparan sulfate
9. Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes
10. Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: Molecular clues for its activity in nephropathy
11. Effect of intraperitoneally administered agents on human peritoneal mesothelial cell growth
12. Heparin reduces the synthesis of collagenous proteins in rat glomerular mesangial cells
13. Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells
14. Heparin potentiation of 3T3-adipocyte stimulated angiogenesis: Mechanisms of action of endothelial cells
15. Effects of heparin on vascularization of artificial skin grafts in rats
16. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone
17. Heparin in the treatment of experimental peritonitis
18. The source and possible significance of hyaluronan in the peritoneal cavity
19. Extracellular matrix hyaluronan is a determinant of the endothelial barrier
20. Glycosaminoglycan chondroitin sulfate prevents loss of ultrafiltration during peritoneal dialysis in rats
21. Protective effect of hyaluronic acid against peritoneal injury
22. N-Acetylglucosamine changes permeability of peritoneum during chronic peritoneal dialysis in rats
23. Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis
24. Hyaluronan preserves peritoneal membrane transport properties
25. Dialysis solution containing hyaluronan: Effect on peritoneal permeability and inflammation in rats
26. Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis
27. Interference of heparin with peritoneal solute transport
28. Effect of intraperitoneal administration of heparin on advanced glycation end-products in CAPD
29. Use of glycosaminoglycans to increase efficiency of long-term continuous peritoneal dialysis